#ExpertTalk: Targeting an Endogenous Retrovirus as a Therapeutic Approach to ALS @EverythingALS
#ExpertTalk: Targeting an Endogenous Retrovirus as a Therapeutic Approach to ALS  @EverythingALS
Uploaded January 2025 | Updated November 2026, 1 day ago
Welcome to another enlightening #experttalk by the EverythingALS, where we delve into cutting-edge research and innovative approaches to combating #ALS (Amyotrophic Lateral Sclerosis).

This discussion dives into the science behind endogenous retroviruses (ERVs), their role in neurodegenerative diseases, and how understanding them could pave the way for innovative treatments for ALS.

πŸ•’ Timestamps
0:00 – Introduction
Meet the speakers and an overview of the session.

3:45 – Understanding Endogenous Retroviruses
What are ERVs, and why are they significant in neurodegenerative diseases?

10:20 – The Role of ERVs in ALS Pathology
How ERVs influence ALS development and progression.

20:15 – Innovative Therapeutic Strategies
Exploring cutting-edge research and treatment possibilities targeting ERVs.

30:50 – Q&A with the Experts
Addressing audience questions and discussing the future of ALS therapies.

40:25 – Closing Remarks
Final insights and takeaways from the session.

πŸ‘©β€πŸ”¬ About EverythingALS:
EverythingALS is a patient-focused nonprofit organization dedicated to accelerating the discovery of treatments and a cure for ALS through collaboration, innovation, and empowering patients and researchers.

πŸ“© Stay Connected:
Subscribe to our channel and turn on notifications to stay updated on the latest expert talks and research breakthroughs in ALS.

πŸ’‘ Don’t forget to:
βœ… Like this video if you found it helpful!
βœ… Subscribe to our channel for more expert talks and updates: [EverythingALS YouTube Channel].
βœ… Share this video to spread awareness and support ALS research.

πŸ“Œ For more resources and to participate in EverythingALS initiatives, visit: everythingals.org

#ALS #EndogenousRetrovirus #ALSResearch #TherapeuticApproach #EverythingALS #Neurodegeneration
#ExpertTalk: Targeting an Endogenous Retrovirus as a Therapeutic Approach to ALSEverythingALS Radcliff Study IntroductionNeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker StudyHappy birthday Peter - July 2nd 2022Crowdsourcing: Accelerating Genetic Findings through the ALS Compute Project by Dr. John LandersVirtually bringing comfort & safety to your homeYou don’t have to be a scientist to think critically about research with Dr. Lyle OstrowDr. Richard Bedlack Introduces the ROARS HMB StudyCitizen led research in ALSOctober 15 - EverythingALS & Dr. Richard BedlackEverythingALS pALS Advisory CommitteeNewsflash: Amylyx: RELYVRIO by Sabrina  Paganoni
Everything ALS |

#ExpertTalk: Targeting an Endogenous Retrovirus as a Therapeutic Approach to ALS

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER